Are you generating the highest quality study data?

Managing risk and generating high quality data is particularly difficult in respiratory clinical trials. Complex protocols, lack of training, and inconsistencies in lung function parameter collection and analysis create uncertainty about patient eligibility, safety, and compound efficacy. Fully compliant with the 2019 ATS/ERS standards, ERT is driving a new era of data quality by reducing the incidence of implausible data and changes in function associated with suboptimal coaching.


By choosing ERT, you get much more than technology to measure lung function.

Historic site performance review optimizes your study site selection and feasibility

Site Selection

Software customization and integrated devices exceed ATS/ERS guidelines

Customized Software and Workflow

Critical training ensures sites understand objectives and maximizes first-time quality

User Training

Central quality review of site data lowers costs and drives reliability

Data Quality Review

Business intelligence helps proactively identify site and patient risks for increased study power

Data Analysis



Asthma Trials

Capture pulmonary function test data along with symptoms of asthma exacerbations, like breathlessness, chest pain, cough, and wheezing to help improve patients’ quality of life. ERT’s integrated solution will ensure you are collecting acceptable data for your study’s regulatory submissions.

Learn More

COPD Trials

COPD Trials

Demonstrate your Chronic Obstructive Pulmonary Disease (COPD) study’s efficacy in improving lung function and quality of life symptoms with improved data acceptability and exacerbation event capture. ERT’s respiratory solution helps you meet your study goals.

Learn More

Cystic Fibrosis Trials

Cystic Fibrosis Trials

Identify the right endpoints for your complex cystic fibrosis (CF) trials. ERT has solutions that measure multiple lung function parameters and can be integrated with other endpoint measurement data solutions.

Learn More

Disease Progression Trials

Lung Safety and Disease Progression Trials

Because decline in respiratory function is a direct result of progression of certain non-pulmonary diseases, demonstrating a treatment benefit on respiratory endpoints may provide evidence of your drug’s effectiveness. ERT enables precise lung function testing integrated with other efficacy data points like patient-reported outcomes (PRO) and more.

Learn More

Idiopathic Pulmonary Fibrosis

IPF Trials

Measure lung diffusion to monitor your Idiopathic Pulmonary Fibrosis (IPF) drug’s efficacy. Managing data variability is critical in demonstrating your compound improves clinically-measured outcomes. ERT’s lung function testing devices, software and services will ensure acceptable data.

Learn More

Home Spirometry

Home Spirometry

Spirometry collection at home, by patient, or with home nurse integrates with other ERT at-home solutions to keep patients safe and studies on track.

Learn More


Collects respiratory patient questionnaires for real-time insights into patient safety and study performance.

Learn More

Cardiac Safety

Captures, reads, and stores ECGs centrally to avoid the risk of false or inaccurate data.

Learn More


Measures and analyzes imaging endpoints like chest computed tomography (CT) to provide on-demand evidence of drug safety and efficacy.

Learn More

Talk to a Specialist

Our team of experts is available to address questions you may have about our integrated respiratory solutions. Submit your contact information and we’ll be in touch shortly.